Peter Longo

Peter Longo is senior managing director of investments at CI and has spent over 24 years in numerous roles at CI. Peter is responsible for evaluating investment opportunities, structuring investments and monitoring portfolio companies through active board participation. Peter’s past CI investments include: Achillion Pharmaceuticals (IPO), Cardium Health (acquired by Centene), CYA Technologies (acquired by enChoice), Aventri fka eTouches (acquired by HGGC), NeuVis (acquired by Rational Software), Nufern (acquired by Rofin-Sinar), SilverSky (acquired by BAE Systems), PCC Technology Group (acquired by Clearview Capital), Device42 (acquired by private equity syndicate) and Post-N-Track (management buyout).

Peter also serves on the board of the Yale Innovation Fund, the Invest Michigan Investment Review Committee and served on the University of Connecticut patent review committee.